

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gas transport (GO:0015669) | 8.78778233 |
| 2 | hemidesmosome assembly (GO:0031581) | 7.51337538 |
| 3 | positive regulation of respiratory burst (GO:0060267) | 7.10653614 |
| 4 | angiotensin maturation (GO:0002003) | 6.97469051 |
| 5 | complement activation, classical pathway (GO:0006958) | 6.60893730 |
| 6 | response to interferon-alpha (GO:0035455) | 6.55192042 |
| 7 | antibacterial humoral response (GO:0019731) | 6.18820669 |
| 8 | positive regulation of pseudopodium assembly (GO:0031274) | 6.12532868 |
| 9 | regulation of cellular extravasation (GO:0002691) | 6.04620900 |
| 10 | antimicrobial humoral response (GO:0019730) | 6.02584408 |
| 11 | glomerular filtration (GO:0003094) | 6.01749344 |
| 12 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.75993088 |
| 13 | regulation of guanylate cyclase activity (GO:0031282) | 5.65987342 |
| 14 | T cell lineage commitment (GO:0002360) | 5.62664624 |
| 15 | regulation of pseudopodium assembly (GO:0031272) | 5.52484626 |
| 16 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.40751643 |
| 17 | complement activation (GO:0006956) | 5.28419279 |
| 18 | intestinal absorption (GO:0050892) | 4.96082638 |
| 19 | bone resorption (GO:0045453) | 4.88721494 |
| 20 | NADH metabolic process (GO:0006734) | 4.70356211 |
| 21 | type I interferon signaling pathway (GO:0060337) | 4.68808427 |
| 22 | cellular response to type I interferon (GO:0071357) | 4.68808427 |
| 23 | cellular response to interferon-alpha (GO:0035457) | 4.67993220 |
| 24 | response to type I interferon (GO:0034340) | 4.62453889 |
| 25 | regulation of respiratory burst (GO:0060263) | 4.60129903 |
| 26 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.44336115 |
| 27 | regulation of cardioblast proliferation (GO:0003264) | 4.24794705 |
| 28 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.24794705 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.17136335 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.16986262 |
| 31 | cellular response to virus (GO:0098586) | 4.10103743 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.94740875 |
| 33 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.90143757 |
| 34 | protein activation cascade (GO:0072376) | 3.89820387 |
| 35 | kidney mesenchyme development (GO:0072074) | 3.89093087 |
| 36 | metanephric mesenchyme development (GO:0072075) | 3.86850754 |
| 37 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.79756628 |
| 38 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.79756628 |
| 39 | endocrine process (GO:0050886) | 3.79756628 |
| 40 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.71656462 |
| 41 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68519628 |
| 42 | regulation of cGMP biosynthetic process (GO:0030826) | 3.68433002 |
| 43 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.67822172 |
| 44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.67460885 |
| 45 | lipoprotein transport (GO:0042953) | 3.66961613 |
| 46 | fructose metabolic process (GO:0006000) | 3.60105730 |
| 47 | GDP-mannose metabolic process (GO:0019673) | 3.58102076 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 3.57965503 |
| 49 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.56651249 |
| 50 | homeostasis of number of cells within a tissue (GO:0048873) | 3.49860747 |
| 51 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.47564202 |
| 52 | regulation of systemic arterial blood pressure (GO:0003073) | 3.47561603 |
| 53 | humoral immune response (GO:0006959) | 3.46103675 |
| 54 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.44682714 |
| 55 | hormone catabolic process (GO:0042447) | 3.33082830 |
| 56 | peptide catabolic process (GO:0043171) | 3.32710475 |
| 57 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.31250687 |
| 58 | protein heterotrimerization (GO:0070208) | 3.27002099 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24969470 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 3.24747927 |
| 61 | virion attachment to host cell (GO:0019062) | 3.24747927 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.24381310 |
| 63 | myoblast migration (GO:0051451) | 3.24318848 |
| 64 | arginine metabolic process (GO:0006525) | 3.21341120 |
| 65 | regulation of cGMP metabolic process (GO:0030823) | 3.20449504 |
| 66 | nephron tubule formation (GO:0072079) | 3.19740446 |
| 67 | urea cycle (GO:0000050) | 3.18906048 |
| 68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.18142973 |
| 69 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.17719869 |
| 70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16552756 |
| 71 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16552756 |
| 72 | epoxygenase P450 pathway (GO:0019373) | 3.14124503 |
| 73 | renal system process involved in regulation of blood volume (GO:0001977) | 3.12734442 |
| 74 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.10418230 |
| 75 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.10405782 |
| 76 | regulation of extracellular matrix disassembly (GO:0010715) | 3.09163320 |
| 77 | peptide hormone processing (GO:0016486) | 3.08120873 |
| 78 | cell-substrate junction assembly (GO:0007044) | 3.07526927 |
| 79 | vitamin A metabolic process (GO:0006776) | 3.06794419 |
| 80 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.05574417 |
| 81 | regulation of response to interferon-gamma (GO:0060330) | 3.05098347 |
| 82 | oligosaccharide biosynthetic process (GO:0009312) | 3.04961591 |
| 83 | response to interferon-beta (GO:0035456) | 2.99080240 |
| 84 | negative regulation of leukocyte migration (GO:0002686) | 2.98657622 |
| 85 | transcytosis (GO:0045056) | 2.98596843 |
| 86 | urea metabolic process (GO:0019627) | 2.98479976 |
| 87 | diacylglycerol metabolic process (GO:0046339) | 2.98298481 |
| 88 | digestion (GO:0007586) | 2.98015959 |
| 89 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.97475610 |
| 90 | negative regulation of signal transduction in absence of ligand (GO:1901099) | 2.95882603 |
| 91 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240) | 2.95882603 |
| 92 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.95256774 |
| 93 | ethanol oxidation (GO:0006069) | 2.95243081 |
| 94 | positive regulation of macrophage cytokine production (GO:0060907) | 2.95035954 |
| 95 | positive regulation of interferon-alpha production (GO:0032727) | 2.94712368 |
| 96 | midgut development (GO:0007494) | 2.93070015 |
| 97 | cGMP-mediated signaling (GO:0019934) | 2.91703861 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 2.90651980 |
| 99 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.89290760 |
| 100 | cyclooxygenase pathway (GO:0019371) | 2.87941080 |
| 101 | positive regulation of hair cycle (GO:0042635) | 2.87923765 |
| 102 | positive regulation of hair follicle development (GO:0051798) | 2.87923765 |
| 103 | lipid particle organization (GO:0034389) | 2.86188441 |
| 104 | peripheral nervous system axon ensheathment (GO:0032292) | 2.84040842 |
| 105 | myelination in peripheral nervous system (GO:0022011) | 2.84040842 |
| 106 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.83362311 |
| 107 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.83115344 |
| 108 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.83072543 |
| 109 | adhesion of symbiont to host (GO:0044406) | 2.80162895 |
| 110 | glycolipid catabolic process (GO:0019377) | 2.79864964 |
| 111 | anatomical structure regression (GO:0060033) | 2.79247897 |
| 112 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.79077248 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77252251 |
| 114 | outer ear morphogenesis (GO:0042473) | 2.75977300 |
| 115 | cell proliferation involved in metanephros development (GO:0072203) | 2.75573958 |
| 116 | glycosphingolipid catabolic process (GO:0046479) | 2.75142429 |
| 117 | regulation of interferon-alpha production (GO:0032647) | 2.73967607 |
| 118 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.73796411 |
| 119 | low-density lipoprotein particle remodeling (GO:0034374) | 2.73692736 |
| 120 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.72300028 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71652300 |
| 122 | lipoprotein metabolic process (GO:0042157) | 2.70178190 |
| 123 | arginine catabolic process (GO:0006527) | 2.70128386 |
| 124 | cell differentiation involved in metanephros development (GO:0072202) | 2.69364171 |
| 125 | epithelial structure maintenance (GO:0010669) | 2.69354719 |
| 126 | carnitine shuttle (GO:0006853) | 2.69243924 |
| 127 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.69028680 |
| 128 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.68279589 |
| 129 | bile acid and bile salt transport (GO:0015721) | 2.64751526 |
| 130 | positive regulation of cGMP metabolic process (GO:0030825) | 2.63063592 |
| 131 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.62599492 |
| 132 | fatty acid transmembrane transport (GO:1902001) | 2.62451018 |
| 133 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.62246935 |
| 134 | disruption of cells of other organism (GO:0044364) | 2.59551097 |
| 135 | killing of cells of other organism (GO:0031640) | 2.59551097 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.59453119 |
| 137 | regulation of RIG-I signaling pathway (GO:0039535) | 2.59225880 |
| 138 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.58641728 |
| 139 | drug metabolic process (GO:0017144) | 2.58521856 |
| 140 | cellular response to interferon-gamma (GO:0071346) | 2.58168151 |
| 141 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.57544698 |
| 142 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.56048531 |
| 143 | negative regulation of interleukin-10 production (GO:0032693) | 2.55655604 |
| 144 | glomerulus development (GO:0032835) | 2.55622509 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.54605056 |
| 146 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.53867197 |
| 147 | O-glycan processing (GO:0016266) | 2.53801667 |
| 148 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.53499149 |
| 149 | response to nitric oxide (GO:0071731) | 2.53131662 |
| 150 | digestive system process (GO:0022600) | 2.53082169 |
| 151 | regulation of hair follicle development (GO:0051797) | 2.51521899 |
| 152 | respiratory tube development (GO:0030323) | 2.50068065 |
| 153 | response to interferon-gamma (GO:0034341) | 2.48959987 |
| 154 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.48819023 |
| 155 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.48819023 |
| 156 | fibril organization (GO:0097435) | 2.48485508 |
| 157 | negative regulation of kidney development (GO:0090185) | 2.48211026 |
| 158 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46971593 |
| 159 | cellular response to cadmium ion (GO:0071276) | 2.46740051 |
| 160 | glucuronate metabolic process (GO:0019585) | 2.46511534 |
| 161 | aorta morphogenesis (GO:0035909) | 2.45449503 |
| 162 | cellular response to nicotine (GO:0071316) | 2.44991912 |
| 163 | cellular response to prostaglandin stimulus (GO:0071379) | 2.44507877 |
| 164 | cell proliferation involved in kidney development (GO:0072111) | 2.44144981 |
| 165 | keratan sulfate catabolic process (GO:0042340) | 2.43422433 |
| 166 | cortical actin cytoskeleton organization (GO:0030866) | 2.42642189 |
| 167 | cellular response to vitamin (GO:0071295) | 2.42488360 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41908338 |
| 169 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.40569419 |
| 170 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.40252698 |
| 171 | negative regulation of protein autophosphorylation (GO:0031953) | 2.39245143 |
| 172 | extracellular matrix assembly (GO:0085029) | 2.38515259 |
| 173 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.38449317 |
| 174 | negative regulation of lipid storage (GO:0010888) | 2.38093554 |
| 175 | endodermal cell differentiation (GO:0035987) | 2.35942862 |
| 176 | positive regulation of autophagy (GO:0010508) | 2.34857489 |
| 177 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.33462317 |
| 178 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.32814010 |
| 179 | cellular response to interleukin-6 (GO:0071354) | 2.32645973 |
| 180 | fatty acid homeostasis (GO:0055089) | 2.27856337 |
| 181 | apoptotic cell clearance (GO:0043277) | 2.26234393 |
| 182 | ganglion development (GO:0061548) | 2.23362393 |
| 183 | response to prostaglandin (GO:0034694) | 2.23055860 |
| 184 | axon extension involved in axon guidance (GO:0048846) | 2.22959250 |
| 185 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.22959250 |
| 186 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.22941384 |
| 187 | renal filtration (GO:0097205) | 2.22834527 |
| 188 | thyroid hormone generation (GO:0006590) | 2.20468884 |
| 189 | filopodium assembly (GO:0046847) | 2.20314228 |
| 190 | oxygen transport (GO:0015671) | 14.3660035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.96578187 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.32694934 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.71195956 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.47687524 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24863047 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23613247 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04799599 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40664489 |
| 9 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.37767508 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.25780092 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.25554404 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22511261 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.15762051 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.14058306 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02739527 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.95844865 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85598252 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83532204 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82141234 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81433426 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.80145574 |
| 22 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.66905587 |
| 23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.66365699 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62964319 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60995045 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59409244 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58235983 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.57907410 |
| 29 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54981794 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53565820 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53530089 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52708248 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52354114 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52151030 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51428976 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.50552560 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48482851 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.46126393 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44436674 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44436674 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43615968 |
| 42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42446850 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42295813 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41378282 |
| 45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38006813 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33868224 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27459543 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27178549 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25566816 |
| 50 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25566816 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24794102 |
| 52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24259921 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24159906 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23930701 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23907902 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22306053 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22095942 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21295317 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20234276 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19825775 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19816258 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19472372 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18185723 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.17169610 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15969215 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15647791 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15523354 |
| 68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15181250 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14948295 |
| 70 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13122323 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12840909 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12621927 |
| 73 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.11579639 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09503329 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08912410 |
| 76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08912410 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08406751 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08144111 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08032008 |
| 80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07336224 |
| 81 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07039445 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06440575 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05352336 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05155562 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04191801 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03851218 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02891953 |
| 88 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02825198 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02776336 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02776336 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02210882 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01138313 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00988652 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00930635 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00838544 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00838544 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00723538 |
| 98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00723538 |
| 99 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00723538 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00634395 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00071750 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99675639 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99629944 |
| 104 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99238170 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99112342 |
| 106 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98025464 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97548994 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97238539 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97138017 |
| 110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96952323 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96422020 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95512725 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95251379 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94829663 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94669194 |
| 116 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94645290 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93577738 |
| 118 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93251723 |
| 119 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92208753 |
| 120 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91730490 |
| 121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91587463 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89972417 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89888634 |
| 124 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89588469 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88939660 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88578620 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88313719 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88181049 |
| 129 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88044634 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87818017 |
| 131 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86515613 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86313697 |
| 133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86211333 |
| 134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86113074 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85542573 |
| 136 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85236063 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85231199 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83920995 |
| 139 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83462842 |
| 140 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.83203076 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82396921 |
| 142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82221839 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78883423 |
| 144 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.78762456 |
| 145 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78350007 |
| 146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77544144 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76581222 |
| 148 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76285916 |
| 149 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.75997745 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.75897306 |
| 151 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75835717 |
| 152 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75690912 |
| 153 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74510768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.99231632 |
| 2 | MP0005360_urolithiasis | 5.14658554 |
| 3 | MP0005275_abnormal_skin_tensile | 4.18014292 |
| 4 | MP0004510_myositis | 4.07187375 |
| 5 | MP0001346_abnormal_lacrimal_gland | 4.06557546 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.78410340 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.57014142 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.47064517 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.30368599 |
| 10 | MP0003724_increased_susceptibility_to | 2.86120337 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.84982822 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.74704165 |
| 13 | MP0000579_abnormal_nail_morphology | 2.71302579 |
| 14 | MP0009840_abnormal_foam_cell | 2.65811584 |
| 15 | MP0004272_abnormal_basement_membrane | 2.65310152 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.50735717 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.46003348 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.45191234 |
| 19 | MP0000751_myopathy | 2.30669779 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.25110354 |
| 21 | MP0002060_abnormal_skin_morphology | 2.23333524 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.19123601 |
| 23 | MP0000467_abnormal_esophagus_morphology | 2.17498959 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.17074478 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.11020903 |
| 26 | MP0005166_decreased_susceptibility_to | 2.02916146 |
| 27 | MP0003866_abnormal_defecation | 1.99079670 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.93324280 |
| 29 | MP0005365_abnormal_bile_salt | 1.91077977 |
| 30 | MP0001664_abnormal_digestion | 1.90902665 |
| 31 | MP0000685_abnormal_immune_system | 1.88671606 |
| 32 | MP0001853_heart_inflammation | 1.76927356 |
| 33 | MP0001873_stomach_inflammation | 1.76808464 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.74718869 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.73342860 |
| 36 | MP0005451_abnormal_body_composition | 1.69640273 |
| 37 | MP0000490_abnormal_crypts_of | 1.66189509 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.63371050 |
| 39 | MP0006054_spinal_hemorrhage | 1.62901838 |
| 40 | MP0000477_abnormal_intestine_morphology | 1.62498372 |
| 41 | MP0005409_darkened_coat_color | 1.61217933 |
| 42 | MP0001663_abnormal_digestive_system | 1.60543154 |
| 43 | MP0000383_abnormal_hair_follicle | 1.59984240 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.59715954 |
| 45 | MP0000733_abnormal_muscle_development | 1.59052563 |
| 46 | MP0003436_decreased_susceptibility_to | 1.55784285 |
| 47 | MP0000762_abnormal_tongue_morphology | 1.55602466 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.50465584 |
| 49 | MP0010678_abnormal_skin_adnexa | 1.50293476 |
| 50 | MP0005023_abnormal_wound_healing | 1.49117361 |
| 51 | MP0004147_increased_porphyrin_level | 1.43611449 |
| 52 | MP0002006_tumorigenesis | 1.42672607 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.40282623 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.39268224 |
| 55 | MP0002098_abnormal_vibrissa_morphology | 1.37400515 |
| 56 | MP0008004_abnormal_stomach_pH | 1.34447789 |
| 57 | MP0004130_abnormal_muscle_cell | 1.33820999 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.32930465 |
| 59 | MP0006082_CNS_inflammation | 1.31608358 |
| 60 | MP0005025_abnormal_response_to | 1.30963397 |
| 61 | MP0009785_altered_susceptibility_to | 1.30584401 |
| 62 | MP0000462_abnormal_digestive_system | 1.29460321 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.29053041 |
| 64 | MP0002796_impaired_skin_barrier | 1.27242123 |
| 65 | MP0000427_abnormal_hair_cycle | 1.26814866 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.26597890 |
| 67 | MP0000604_amyloidosis | 1.23565425 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.20801657 |
| 69 | MP0003045_fibrosis | 1.20728968 |
| 70 | * MP0001845_abnormal_inflammatory_respons | 1.18787622 |
| 71 | MP0002108_abnormal_muscle_morphology | 1.18307960 |
| 72 | MP0005332_abnormal_amino_acid | 1.16134160 |
| 73 | * MP0005387_immune_system_phenotype | 1.15858869 |
| 74 | * MP0001790_abnormal_immune_system | 1.15858869 |
| 75 | MP0000681_abnormal_thyroid_gland | 1.11484700 |
| 76 | MP0003329_amyloid_beta_deposits | 1.10845405 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.10033610 |
| 78 | MP0005165_increased_susceptibility_to | 1.08852680 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.06807221 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.06680963 |
| 81 | MP0001756_abnormal_urination | 1.06323043 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 1.06006457 |
| 83 | MP0000749_muscle_degeneration | 1.04433673 |
| 84 | MP0002136_abnormal_kidney_physiology | 1.03713583 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.03675301 |
| 86 | MP0003448_altered_tumor_morphology | 1.02863944 |
| 87 | MP0003941_abnormal_skin_development | 1.01558973 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 1.00073438 |
| 89 | MP0003091_abnormal_cell_migration | 0.97435608 |
| 90 | MP0003868_abnormal_feces_composition | 0.97284278 |
| 91 | MP0001835_abnormal_antigen_presentation | 0.97281111 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.97096929 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.97088542 |
| 94 | MP0003252_abnormal_bile_duct | 0.95950478 |
| 95 | MP0009764_decreased_sensitivity_to | 0.95594245 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.94670731 |
| 97 | MP0009250_abnormal_appendicular_skeleto | 0.93572282 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.92898412 |
| 99 | MP0000613_abnormal_salivary_gland | 0.92682459 |
| 100 | MP0001849_ear_inflammation | 0.92569554 |
| 101 | MP0001958_emphysema | 0.92009075 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.91747373 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.91727189 |
| 104 | MP0006138_congestive_heart_failure | 0.91509684 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.91411107 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.91009495 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.90018704 |
| 108 | MP0000566_synostosis | 0.89133882 |
| 109 | MP0003279_aneurysm | 0.87790130 |
| 110 | MP0000538_abnormal_urinary_bladder | 0.87785989 |
| 111 | MP0002933_joint_inflammation | 0.87138778 |
| 112 | MP0001542_abnormal_bone_strength | 0.86794452 |
| 113 | MP0000377_abnormal_hair_follicle | 0.85805377 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.85334490 |
| 115 | MP0002233_abnormal_nose_morphology | 0.85062628 |
| 116 | MP0003828_pulmonary_edema | 0.84906906 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.84816215 |
| 118 | MP0005508_abnormal_skeleton_morphology | 0.84782193 |
| 119 | MP0003385_abnormal_body_wall | 0.84447882 |
| 120 | MP0001800_abnormal_humoral_immune | 0.83881766 |
| 121 | MP0000249_abnormal_blood_vessel | 0.83855065 |
| 122 | MP0003075_altered_response_to | 0.81586983 |
| 123 | MP0000343_altered_response_to | 0.80502935 |
| 124 | MP0004858_abnormal_nervous_system | 0.80358435 |
| 125 | MP0002234_abnormal_pharynx_morphology | 0.79179180 |
| 126 | MP0004947_skin_inflammation | 0.78933488 |
| 127 | MP0005000_abnormal_immune_tolerance | 0.78692136 |
| 128 | MP0000750_abnormal_muscle_regeneration | 0.78566754 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.78489050 |
| 130 | MP0010771_integument_phenotype | 0.77095484 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.76687160 |
| 132 | MP0001764_abnormal_homeostasis | 0.75447237 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.75335168 |
| 134 | MP0001881_abnormal_mammary_gland | 0.74941402 |
| 135 | MP0001243_abnormal_dermal_layer | 0.74815924 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.74653461 |
| 137 | MP0008469_abnormal_protein_level | 0.73790626 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.73682615 |
| 139 | MP0005369_muscle_phenotype | 0.72628402 |
| 140 | MP0009278_abnormal_bone_marrow | 0.72034165 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.70780006 |
| 142 | MP0002009_preneoplasia | 0.70585825 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70413660 |
| 144 | MP0002106_abnormal_muscle_physiology | 0.69662299 |
| 145 | MP0000759_abnormal_skeletal_muscle | 0.69289438 |
| 146 | MP0003806_abnormal_nucleotide_metabolis | 0.69205206 |
| 147 | MP0003795_abnormal_bone_structure | 0.69120390 |
| 148 | MP0002269_muscular_atrophy | 0.68741900 |
| 149 | MP0001501_abnormal_sleep_pattern | 0.68203151 |
| 150 | MP0003303_peritoneal_inflammation | 0.67830742 |
| 151 | MP0002896_abnormal_bone_mineralization | 0.67611756 |
| 152 | MP0002419_abnormal_innate_immunity | 0.67544697 |
| 153 | MP0005670_abnormal_white_adipose | 0.67480192 |
| 154 | MP0000627_abnormal_mammary_gland | 0.67012987 |
| 155 | MP0002168_other_aberrant_phenotype | 0.65315036 |
| 156 | MP0009115_abnormal_fat_cell | 0.64679307 |
| 157 | MP0005330_cardiomyopathy | 0.63650501 |
| 158 | MP0000678_abnormal_parathyroid_gland | 0.62685877 |
| 159 | MP0005390_skeleton_phenotype | 0.61839934 |
| 160 | MP0005375_adipose_tissue_phenotype | 0.60957542 |
| 161 | MP0001270_distended_abdomen | 0.60722681 |
| 162 | MP0002332_abnormal_exercise_endurance | 0.59054546 |
| 163 | MP0001851_eye_inflammation | 0.58656169 |
| 164 | MP0002972_abnormal_cardiac_muscle | 0.58451573 |
| 165 | MP0000516_abnormal_urinary_system | 0.57355747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.26217682 |
| 2 | Malnutrition (HP:0004395) | 6.36087523 |
| 3 | Milia (HP:0001056) | 4.90186288 |
| 4 | Atrophic scars (HP:0001075) | 4.86688041 |
| 5 | Vertebral compression fractures (HP:0002953) | 4.67278435 |
| 6 | Natal tooth (HP:0000695) | 4.62373530 |
| 7 | Abnormality of complement system (HP:0005339) | 4.44622064 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.32999877 |
| 9 | Onycholysis (HP:0001806) | 4.24264082 |
| 10 | Follicular hyperkeratosis (HP:0007502) | 4.21153692 |
| 11 | Abnormality of the fingertips (HP:0001211) | 4.20543610 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 4.03917003 |
| 13 | Ankle contracture (HP:0006466) | 3.92821960 |
| 14 | Glomerulonephritis (HP:0000099) | 3.75773882 |
| 15 | Lip pit (HP:0100267) | 3.75657681 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 3.72523882 |
| 17 | Plantar hyperkeratosis (HP:0007556) | 3.64533114 |
| 18 | Esophageal varix (HP:0002040) | 3.60439587 |
| 19 | Biconcave vertebral bodies (HP:0004586) | 3.50537135 |
| 20 | Increased connective tissue (HP:0009025) | 3.38399919 |
| 21 | Ileus (HP:0002595) | 3.36787781 |
| 22 | Chronic diarrhea (HP:0002028) | 3.32782252 |
| 23 | Fragile nails (HP:0001808) | 3.32484939 |
| 24 | Aplasia cutis congenita (HP:0001057) | 3.29327703 |
| 25 | Fat malabsorption (HP:0002630) | 3.23172256 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 3.13495416 |
| 27 | Advanced eruption of teeth (HP:0006288) | 3.10009659 |
| 28 | Colitis (HP:0002583) | 3.09227896 |
| 29 | Protrusio acetabuli (HP:0003179) | 3.06307535 |
| 30 | Tetraparesis (HP:0002273) | 3.05073247 |
| 31 | Pili torti (HP:0003777) | 3.00683103 |
| 32 | Abnormal hair laboratory examination (HP:0003328) | 2.97984656 |
| 33 | Dry hair (HP:0011359) | 2.94222010 |
| 34 | Nasolacrimal duct obstruction (HP:0000579) | 2.93239370 |
| 35 | Broad metatarsal (HP:0001783) | 2.92168122 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.91333759 |
| 37 | Exercise-induced myalgia (HP:0003738) | 2.90878080 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.86673591 |
| 39 | Beaking of vertebral bodies (HP:0004568) | 2.85320868 |
| 40 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.84926847 |
| 41 | Wormian bones (HP:0002645) | 2.83850444 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80925864 |
| 43 | Spontaneous abortion (HP:0005268) | 2.80020876 |
| 44 | Metabolic alkalosis (HP:0200114) | 2.78979949 |
| 45 | Abnormality of vitamin B metabolism (HP:0004340) | 2.76629491 |
| 46 | Alkalosis (HP:0001948) | 2.72337252 |
| 47 | Spinal rigidity (HP:0003306) | 2.71167440 |
| 48 | Growth hormone excess (HP:0000845) | 2.70276887 |
| 49 | Slender build (HP:0001533) | 2.63933371 |
| 50 | Shallow orbits (HP:0000586) | 2.60897806 |
| 51 | Widely patent fontanelles and sutures (HP:0004492) | 2.58232213 |
| 52 | Abnormality of the gastric mucosa (HP:0004295) | 2.57744229 |
| 53 | Thin bony cortex (HP:0002753) | 2.57585946 |
| 54 | Nail dystrophy (HP:0008404) | 2.57386506 |
| 55 | Adactyly (HP:0009776) | 2.56713817 |
| 56 | Hyperactive renin-angiotensin system (HP:0000841) | 2.56571793 |
| 57 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.55927298 |
| 58 | Cervical subluxation (HP:0003308) | 2.54846969 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.53557632 |
| 60 | Emphysema (HP:0002097) | 2.52680960 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.52499165 |
| 62 | Fragile skin (HP:0001030) | 2.51543272 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50276129 |
| 64 | Esophageal atresia (HP:0002032) | 2.50235700 |
| 65 | Epidermoid cyst (HP:0200040) | 2.50047043 |
| 66 | Nausea (HP:0002018) | 2.47059676 |
| 67 | Hypoplasia of dental enamel (HP:0006297) | 2.46679430 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.43564511 |
| 69 | Vascular tortuosity (HP:0004948) | 2.42017359 |
| 70 | Abnormality of the right ventricle (HP:0001707) | 2.39787024 |
| 71 | Skull defect (HP:0001362) | 2.38830031 |
| 72 | Aortic dissection (HP:0002647) | 2.38494199 |
| 73 | IgM deficiency (HP:0002850) | 2.37013111 |
| 74 | Round ear (HP:0100830) | 2.36030085 |
| 75 | Thick nail (HP:0001805) | 2.35996935 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.34089992 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.34065862 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.34065862 |
| 79 | Selective tooth agenesis (HP:0001592) | 2.33366496 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.31583037 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.31186277 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31186277 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.30915260 |
| 84 | Increased purine levels (HP:0004368) | 2.29423830 |
| 85 | Hyperuricemia (HP:0002149) | 2.29423830 |
| 86 | Steatorrhea (HP:0002570) | 2.28275284 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27247994 |
| 88 | Premature rupture of membranes (HP:0001788) | 2.25972507 |
| 89 | Palmoplantar hyperkeratosis (HP:0000972) | 2.25591401 |
| 90 | Wide cranial sutures (HP:0010537) | 2.25153815 |
| 91 | Villous atrophy (HP:0011473) | 2.24038939 |
| 92 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.24038939 |
| 93 | Abdominal distention (HP:0003270) | 2.23553513 |
| 94 | Severe short stature (HP:0003510) | 2.22003841 |
| 95 | Bone cyst (HP:0012062) | 2.21294551 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20333028 |
| 97 | Palmar hyperkeratosis (HP:0010765) | 2.18936988 |
| 98 | Abnormality of vitamin metabolism (HP:0100508) | 2.18009489 |
| 99 | Hyperparathyroidism (HP:0000843) | 2.17804717 |
| 100 | Glycosuria (HP:0003076) | 2.17582252 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.17582252 |
| 102 | Aortic aneurysm (HP:0004942) | 2.17162659 |
| 103 | Porencephaly (HP:0002132) | 2.16733219 |
| 104 | Abnormality of the lacrimal duct (HP:0011481) | 2.15150485 |
| 105 | Abnormality of the ischium (HP:0003174) | 2.15144367 |
| 106 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.14652466 |
| 107 | Xanthomatosis (HP:0000991) | 2.11884595 |
| 108 | Recurrent bronchitis (HP:0002837) | 2.11537034 |
| 109 | Rectal prolapse (HP:0002035) | 2.10231401 |
| 110 | Pigmentary retinal degeneration (HP:0001146) | 2.09258022 |
| 111 | Hyporeflexia of lower limbs (HP:0002600) | 2.05744807 |
| 112 | Acanthosis nigricans (HP:0000956) | 2.04452502 |
| 113 | Abnormality of macrophages (HP:0004311) | 2.03861288 |
| 114 | Thrombocytosis (HP:0001894) | 2.03450773 |
| 115 | Scapular winging (HP:0003691) | 2.02873737 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 2.02696367 |
| 117 | Hyperphosphatemia (HP:0002905) | 2.01249825 |
| 118 | Nephrolithiasis (HP:0000787) | 1.98789268 |
| 119 | Muscle fiber splitting (HP:0003555) | 1.96918997 |
| 120 | Gingivitis (HP:0000230) | 1.96004134 |
| 121 | Abnormal delivery (HP:0001787) | 1.95353808 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.95050375 |
| 123 | Hypophosphatemia (HP:0002148) | 1.94200157 |
| 124 | Arterial tortuosity (HP:0005116) | 1.93856387 |
| 125 | Nephritis (HP:0000123) | 1.93453791 |
| 126 | Fatigable weakness (HP:0003473) | 1.92130880 |
| 127 | Abnormality of the neuromuscular junction (HP:0003398) | 1.92130880 |
| 128 | Hyperextensible skin (HP:0000974) | 1.92023045 |
| 129 | Absent hand (HP:0004050) | 1.91193933 |
| 130 | Confusion (HP:0001289) | 1.90948257 |
| 131 | Hematochezia (HP:0002573) | 1.90021993 |
| 132 | Inflammation of the large intestine (HP:0002037) | 1.89196969 |
| 133 | Cerebral palsy (HP:0100021) | 1.88027927 |
| 134 | Pancreatitis (HP:0001733) | 1.87845491 |
| 135 | Hypotension (HP:0002615) | 1.87367703 |
| 136 | Vasculitis (HP:0002633) | 1.85460913 |
| 137 | Periauricular skin pits (HP:0100277) | 1.85422576 |
| 138 | Preauricular pit (HP:0004467) | 1.85422576 |
| 139 | Abnormality of the nasolacrimal system (HP:0000614) | 1.84405604 |
| 140 | Ventricular tachycardia (HP:0004756) | 1.82951913 |
| 141 | Mixed hearing impairment (HP:0000410) | 1.82862674 |
| 142 | Aneurysm (HP:0002617) | 1.82371930 |
| 143 | Abnormality of the costochondral junction (HP:0000919) | 1.82081532 |
| 144 | Abnormality of purine metabolism (HP:0004352) | 1.81960311 |
| 145 | IgA deficiency (HP:0002720) | 1.79447907 |
| 146 | Bladder diverticulum (HP:0000015) | 1.78983850 |
| 147 | Peritonitis (HP:0002586) | 1.78813690 |
| 148 | Fibular hypoplasia (HP:0003038) | 1.78733592 |
| 149 | Acanthocytosis (HP:0001927) | 1.78467916 |
| 150 | Ulnar claw (HP:0001178) | 1.78424647 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.76174459 |
| 152 | Dysostosis multiplex (HP:0000943) | 1.76123847 |
| 153 | Difficulty running (HP:0009046) | 1.75922618 |
| 154 | Protuberant abdomen (HP:0001538) | 1.75814273 |
| 155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75655900 |
| 156 | Eczematoid dermatitis (HP:0000976) | 1.75318855 |
| 157 | Alopecia of scalp (HP:0002293) | 1.74936849 |
| 158 | Complement deficiency (HP:0004431) | 1.74659766 |
| 159 | Enlarged epiphyses (HP:0010580) | 1.74088623 |
| 160 | Gastrointestinal dysmotility (HP:0002579) | 1.74055957 |
| 161 | Bone pain (HP:0002653) | 1.73409898 |
| 162 | Weak cry (HP:0001612) | 1.73344953 |
| 163 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73000501 |
| 164 | Mitral valve prolapse (HP:0001634) | 1.72920641 |
| 165 | Patent foramen ovale (HP:0001655) | 1.72785602 |
| 166 | Spondylolisthesis (HP:0003302) | 1.72501775 |
| 167 | Ventricular fibrillation (HP:0001663) | 1.71991034 |
| 168 | Nasal polyposis (HP:0100582) | 1.70244955 |
| 169 | Stroke (HP:0001297) | 1.70147993 |
| 170 | Amyloidosis (HP:0011034) | 1.69967619 |
| 171 | Focal segmental glomerulosclerosis (HP:0000097) | 1.69951138 |
| 172 | Hyperammonemia (HP:0001987) | 1.69867887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.95352726 |
| 2 | RIPK1 | 3.90229163 |
| 3 | IKBKE | 3.38765959 |
| 4 | NME1 | 3.17562197 |
| 5 | CLK1 | 3.00095056 |
| 6 | TTN | 2.62580498 |
| 7 | RPS6KA4 | 2.54491034 |
| 8 | GRK6 | 2.48399390 |
| 9 | FGFR4 | 2.47269216 |
| 10 | TBK1 | 2.24743408 |
| 11 | MAPK15 | 2.15415982 |
| 12 | PHKG1 | 2.07068583 |
| 13 | PHKG2 | 2.07068583 |
| 14 | RPS6KB2 | 2.06646600 |
| 15 | EPHA2 | 1.99682779 |
| 16 | ZAK | 1.97171756 |
| 17 | DDR2 | 1.95312984 |
| 18 | TSSK6 | 1.88773981 |
| 19 | TYK2 | 1.87777086 |
| 20 | EPHA3 | 1.86818740 |
| 21 | MAP3K10 | 1.83130081 |
| 22 | CAMK1D | 1.82445396 |
| 23 | GRK1 | 1.77769317 |
| 24 | PIK3CG | 1.71799815 |
| 25 | PIK3CA | 1.71031334 |
| 26 | EPHB1 | 1.67439120 |
| 27 | MAPKAPK3 | 1.66031237 |
| 28 | TGFBR2 | 1.65560097 |
| 29 | LATS1 | 1.63989469 |
| 30 | NUAK1 | 1.52828245 |
| 31 | CHUK | 1.50716308 |
| 32 | JAK1 | 1.50381744 |
| 33 | ERN1 | 1.49357690 |
| 34 | ADRBK2 | 1.48562945 |
| 35 | MAP3K7 | 1.42183428 |
| 36 | CAMK4 | 1.42052178 |
| 37 | TRIB3 | 1.41503394 |
| 38 | STK39 | 1.36196997 |
| 39 | PDGFRA | 1.35164796 |
| 40 | MAP3K12 | 1.35132422 |
| 41 | PTK6 | 1.34837143 |
| 42 | TESK1 | 1.33205495 |
| 43 | TIE1 | 1.32267174 |
| 44 | MAP4K1 | 1.30951992 |
| 45 | PTK2 | 1.28143037 |
| 46 | MYLK | 1.26759607 |
| 47 | ABL2 | 1.23301488 |
| 48 | PRKAA2 | 1.22455214 |
| 49 | MAP3K14 | 1.22453341 |
| 50 | MAP2K2 | 1.12969813 |
| 51 | FGFR1 | 1.12596562 |
| 52 | PRPF4B | 1.10875393 |
| 53 | FGFR3 | 1.10186888 |
| 54 | MST4 | 1.07469154 |
| 55 | FER | 1.07213640 |
| 56 | DAPK2 | 1.06660324 |
| 57 | KIT | 1.05059701 |
| 58 | OXSR1 | 1.02824719 |
| 59 | CAMK1G | 1.02769133 |
| 60 | ZAP70 | 1.02446765 |
| 61 | JAK2 | 1.01761948 |
| 62 | PAK2 | 1.00250983 |
| 63 | FGFR2 | 0.97805898 |
| 64 | IKBKB | 0.94666059 |
| 65 | JAK3 | 0.94350326 |
| 66 | LMTK2 | 0.94149148 |
| 67 | TGFBR1 | 0.93692006 |
| 68 | PRKG2 | 0.92786859 |
| 69 | EPHB2 | 0.90909810 |
| 70 | ERBB3 | 0.84451879 |
| 71 | SIK1 | 0.84346223 |
| 72 | TESK2 | 0.83890355 |
| 73 | STK24 | 0.81546407 |
| 74 | NTRK1 | 0.81025978 |
| 75 | PDPK1 | 0.80175461 |
| 76 | CAMK2G | 0.80127231 |
| 77 | MATK | 0.79334553 |
| 78 | MAP3K11 | 0.77430882 |
| 79 | PAK4 | 0.76063729 |
| 80 | LATS2 | 0.72747966 |
| 81 | HIPK2 | 0.72545835 |
| 82 | ADRBK1 | 0.70288098 |
| 83 | RIPK4 | 0.69519174 |
| 84 | RPS6KA6 | 0.66573044 |
| 85 | MAPK7 | 0.65740562 |
| 86 | BMPR1B | 0.64705021 |
| 87 | BMX | 0.64516175 |
| 88 | MAP3K3 | 0.64103514 |
| 89 | MAP3K1 | 0.63051540 |
| 90 | MAPKAPK5 | 0.62426442 |
| 91 | MST1R | 0.60856245 |
| 92 | DMPK | 0.58485973 |
| 93 | MET | 0.58376182 |
| 94 | DYRK1B | 0.57891501 |
| 95 | PTK2B | 0.55422249 |
| 96 | PRKAA1 | 0.54502028 |
| 97 | IRAK1 | 0.54076037 |
| 98 | BTK | 0.53631321 |
| 99 | LRRK2 | 0.52597456 |
| 100 | CDK6 | 0.52323682 |
| 101 | TAOK1 | 0.51645379 |
| 102 | SMG1 | 0.49840045 |
| 103 | KDR | 0.48233421 |
| 104 | EGFR | 0.48185321 |
| 105 | ERBB2 | 0.48127137 |
| 106 | SRC | 0.47581663 |
| 107 | MAP2K1 | 0.46978125 |
| 108 | BCR | 0.46226061 |
| 109 | PRKCD | 0.44956718 |
| 110 | BLK | 0.44719534 |
| 111 | GSK3A | 0.44310783 |
| 112 | MAPKAPK2 | 0.42356671 |
| 113 | ERBB4 | 0.42040648 |
| 114 | OBSCN | 0.40878164 |
| 115 | CAMK2D | 0.39670244 |
| 116 | KSR2 | 0.39622391 |
| 117 | PIM2 | 0.39439575 |
| 118 | DAPK3 | 0.39238483 |
| 119 | PRKACG | 0.39122114 |
| 120 | PRKCA | 0.38998735 |
| 121 | NLK | 0.38530512 |
| 122 | CDC42BPA | 0.38380995 |
| 123 | MTOR | 0.37937320 |
| 124 | LYN | 0.37527687 |
| 125 | PRKD1 | 0.37346304 |
| 126 | MAP3K2 | 0.36961038 |
| 127 | PAK3 | 0.36951777 |
| 128 | PDK1 | 0.36873384 |
| 129 | MAPK11 | 0.36345455 |
| 130 | RPS6KA5 | 0.36173486 |
| 131 | RET | 0.35616248 |
| 132 | STK10 | 0.35117101 |
| 133 | ROCK1 | 0.34640800 |
| 134 | RPS6KL1 | 0.34488983 |
| 135 | RPS6KC1 | 0.34488983 |
| 136 | PDK4 | 0.33812613 |
| 137 | PDK3 | 0.33812613 |
| 138 | PRKCZ | 0.33403616 |
| 139 | INSR | 0.33369888 |
| 140 | VRK1 | 0.33267484 |
| 141 | IGF1R | 0.33093342 |
| 142 | PRKD2 | 0.32817671 |
| 143 | CDK19 | 0.32664178 |
| 144 | CSK | 0.32035708 |
| 145 | GRK5 | 0.31624614 |
| 146 | PDK2 | 0.31562617 |
| 147 | PDGFRB | 0.31497575 |
| 148 | BMPR2 | 0.31053766 |
| 149 | TXK | 0.30869169 |
| 150 | ILK | 0.29903013 |
| 151 | TNIK | 0.29885772 |
| 152 | FYN | 0.27900919 |
| 153 | RPS6KA2 | 0.26984851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.14956166 |
| 2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.03876547 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.88821654 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.88474460 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 2.49003919 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.16096483 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10988781 |
| 8 | * Asthma_Homo sapiens_hsa05310 | 1.89388465 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.88755868 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.87786397 |
| 11 | Amoebiasis_Homo sapiens_hsa05146 | 1.80308793 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.75871049 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74496654 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74217360 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.73917175 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.72434601 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.71535911 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71055686 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70976125 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70781582 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.67840545 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66491187 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65612295 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60996805 |
| 25 | Focal adhesion_Homo sapiens_hsa04510 | 1.60995556 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53708138 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.44365058 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42938629 |
| 29 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.41712872 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39862965 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.37623093 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34880288 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30895978 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.30275960 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29410430 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28294284 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27950944 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25018089 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24766491 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24183529 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23587694 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22935003 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22716728 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.21843209 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20772573 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.19776281 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.18787070 |
| 48 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18727580 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17969003 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17898508 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16482870 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15395688 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.12896358 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12847758 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11612805 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11036993 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09652903 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.08620136 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08474382 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08151984 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.02270411 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02163135 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01473343 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99413829 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98599509 |
| 66 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.96733421 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.90537091 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89819769 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89425401 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.87482207 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86986750 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86529618 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85945308 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85736187 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85384380 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85030920 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83434705 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82526207 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82198977 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79293972 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76483739 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75434208 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.75328213 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73393642 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73226690 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71574955 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71551839 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.71411804 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71343155 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71223237 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71076819 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70853938 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68695034 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.68654299 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67370255 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66493733 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64011581 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63672067 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63157660 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63080039 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63016394 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61625872 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.61172638 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60755851 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60571511 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60152381 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.58033949 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56630188 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55051029 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53986164 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.53101012 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51975958 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51973616 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51544187 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51296258 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50537751 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50247917 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49488590 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49240802 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48651196 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47563303 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47083002 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46756655 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45541218 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44147765 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44104150 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42974491 |
| 128 | Gap junction_Homo sapiens_hsa04540 | 0.42849235 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42712441 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42258821 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42081775 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41649561 |
| 133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41327649 |
| 134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40455039 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.40197046 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.39667207 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39057565 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38969732 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.38895713 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38258680 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37735126 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37600068 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.37562791 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37424462 |
| 145 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36726248 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.36586760 |
| 147 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31153414 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29695598 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26035553 |
| 150 | Peroxisome_Homo sapiens_hsa04146 | 0.24993323 |
| 151 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21566737 |
| 152 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20936556 |

